Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperbaric Oxygen for Treatment of Long COVID Syndrome; A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical Trial

NCT04842448 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT04842448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperbaric Oxygen for Treatment of Long COVID Syndrome; A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical Trial
Lead sponsor
Karolinska University Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 15, 2021
Completion date
June 17, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, post covid condition, post covid-19 condition, post covid-19 condition, unspecified, post-acute covid-19 syndrome, post-covid syndrome